Nanexa (Sweden)
Nanexa AB (publ) (“Nanexa” or the “Company”) today announces the exercise of warrants issued in connection with the Company’s directed issue of units, which was resolved upon by the Board of Directors on 24 January 2025. The directed issue consisted of units in two tranches, of which the first tranche was issued pursuant to the authorization from the Annual General Meeting held on 15 May 2024, and the second tranche was approved by the Extraordinary General Meeting on 13 February 2025. In connec
Basic Information
- Category: business
- Website: http://www.nanexa.com/
Documented Facts
- Email: info@nanexa.se (No linked source recorded for this statement.)
Evidence and Sources
- Nanexa (Sweden) — Official Site (official)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Nanexa (Sweden).
- Canonical profile: https://brandsource.ai/brands/nanexa-sweden
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/nanexa-sweden/json-ld
- Citation profile API: https://brandsource.ai/api/brands/nanexa-sweden/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (77/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Nanexa AB (publ) (“Nanexa” or the “Company”) today announces the exercise of warrants issued in connection with the Company’s directed issue of units, which was resolved upon by the Board of Directors on 24 January 2025. The directed issue consisted of units in two tranches, of which the first tranche was issued pursuant to the authorization from the Annual General Meeting held on 15 May 2024, and the second tranche was approved by the Extraordinary General Meeting on 13 February 2025. In connec
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.